The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer

Critical Care Medicine

Volumn 42, Issue 12, 2014, Pages 2500-2507

  Debiane, Labib ^a   Hachem, Ray Y ^a   Wohoush, Iba Al ^a   Shomali, William ^a   Bahu, Ramez R ^a   Jiang, Ying ^a   Chaftari, Anne Marie ^a   Jabbour, Joseph ^a   Al Shuaibi, Munirah ^a   Hanania, Alexander ^a   Pravinkumar, S Egbert ^a   Schuetz, Philipp ^b   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Medical University Department   (Switzerland)

Author keywords

Bacteremia; Biomarkers; Bloodstream infection; Infection; Proadrenomedullin; Procalcitonin

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; PROADRENOMEDULLIN; PROCALCITONIN; ADRENOMEDULLIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ANTIMICROBIAL THERAPY; APACHE; ARTICLE; BACTEREMIA; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANCER PATIENT; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DISEASE DURATION; FEMALE; FEVER; FUNGEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NEUTROPENIA; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SOLID TUMOR; TREATMENT DURATION; TREATMENT RESPONSE; VERY ELDERLY; VIREMIA; BLOOD; CRITICAL ILLNESS; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SEPSIS;

EID: 84922503194     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000526     Document Type: Article

References (37)

1. Maubon D, Hamidfar-Roy R, Courby S, et al: Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 2010;61:335-342
2. Olofsson SK, Cars O: Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis 2007;45(Suppl 2):S129-S136
3. Ohmagari N, Hanna H, Graviss L, et al: Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 2005;104:205-212
4. Christ-Crain M, Morgenthaler NG, Stolz D, et al: Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care 2006;10:R96
5. Becker KL, Nylén ES, White JC, et al: Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-1525
6. Lelubre C, Anselin S, Zouaoui Boudjeltia K, et al: Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int 2013;2013:124021
7. Jeong S, Park Y, Cho Y, et al: Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture. Clin Chim Acta 2012;413:1731-1736
8. Pierrakos C, Vincent JL: Sepsis biomarkers: A review. Crit Care 2010;14:R15
9. Riedel S, Melendez JH, An AT, et al: Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 2011;135:182-189
10. Bouadma L, Luyt CE, Tubach F, et al; PRORATA trial group: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010;375:463-474
11. Schuetz P, Chiappa V, Briel M, et al: Procalcitonin algorithms for antibiotic therapy decisions: A systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322-1331
12. Hochreiter M, Köhler T, Schweiger AM, et al: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. Crit Care 2009;13:R83
13. Schuetz P, Christ-Crain M, Thomann R, et al; ProHOSP Study Group: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial. JAMA 2009;302:1059-1066
14. Stolz D, Smyrnios N, Eggimann P, et al: Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: A randomised study. Eur Respir J 2009;34:1364-1375
15. Nobre V, Harbarth S, Graf JD, et al: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 2008;177:498-505
16. Christ-Crain M, Morgenthaler NG, Struck J, et al: Mid-regional proadrenomedullin as a prognostic marker in sepsis: An observational study. Crit Care 2005;9:R816-R824
17. Al Shuaibi M, Bahu RR, Chaftari AM, et al: Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis 2013;56:943-950
18. Algeciras-Schimnich A, Preissner CM, Theobald JP, et al: Procalcitonin: A marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2009;94:861-868
19. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874
21. Balk RA: Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin 2000;16:179-192
22. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256
23. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005;365:63-78
24. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845
25. Lorrot M, Moulin F, Coste J, et al: [Procalcitonin in pediatric emergencies: Comparison with C-reactive protein, interleukin-6 and interferon alpha in the differentiation between bacterial and viral infections]. Presse Med 2000;29:128-134
26. Kim DY, Lee YS, Ahn S, et al: The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat 2011;43:176-180
27. Limper M, de Kruif MD, Duits AJ, et al: The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from noninfectious fever. J Infect 2010;60:409-416
28. Luzzani A, Polati E, Dorizzi R, et al: Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003;31:1737-1741
29. Meynaar IA, Droog W, Batstra M, et al: In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract 2011;2011:594645
30. Christ-Crain M, Müller B: Biomarkers in respiratory tract infections: Diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007;30:556-573
31. Schuetz P, Haubitz S, Mueller B: Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care? Curr Opin Crit Care 2012;18:341-349
32. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al: Markers of bacteremia in febrile neutropenic patients with hematological malignancies: Procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004;23:539-544
33. Schuetz P, Mueller B, Trampuz A: Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulasenegative staphylococci. Infection 2007;35:352-355
34. Matzaraki V, Alexandraki KI, Venetsanou K, et al: Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem 2007;40:336-342
35. Matsui E, Kitamura K, Yoshida M, et al: Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock. Hypertens Res 2001;24:543-549
36. Wang RL, Kang FX: Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin. Chin J Traumatol 2010;13:152-157
37. Guignant C, Voirin N, Venet F, et al: Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med 2009;35:1859-1867